Literature DB >> 1353483

Roles of the pap- and prs-encoded adhesins in Escherichia coli adherence to human uroepithelial cells.

I Johanson1, R Lindstedt, C Svanborg.   

Abstract

In this study, we reexamined the structural prerequisites for the attachment of P-fimbriated Escherichia coli to human urinary tract epithelial cells. The epithelial cells were obtained from A1P1 nonsecretor individuals, who express the globoseries of glycolipids without the ABH blood group determinants, and from A1P1 secretor individuals, who in addition express globo-A, a receptor for the prsJ96 adhesin. The wild-type E. coli strains J96, AD110, and IA2 and the recombinant clones HB101 papJ96, HB101 prsJ96, HB101 papIA2, and HB101 papAD110 were tested for binding. They expressed P fimbriae, as defined by P blood group-dependent agglutination of human erythrocytes of the globoseries, but differed in reactivity with galactose alpha 1-4galactose beta (Gal alpha 1-4Gal beta)-latex beads, isolated glycolipids of the globoseries, sheep erythrocytes, and uroepithelial cells. Three different patterns of binding were represented among the recombinant clones. HB101 papIA2 and HB101 papAD110 agglutinated sheep erythrocytes and Gal alpha 1-4Gal beta-latex beads and attached to both secretor and nonsecretor epithelial cells. HB101 prsJ96 agglutinated sheep erythrocytes, reacted poorly with Gal alpha 1-4Gal beta-latex beads, and attached to A1 secretor but not to A1 nonsecretor epithelial cells. HB101 papJ96 agglutinated Gal alpha 1-4Gal beta-latex beads but not sheep erythrocytes and attached poorly to human uroepithelial cells. The receptors relevant for adhesion were analyzed by inhibition with glycolipids in suspension. The sheep erythrocyte agglutination and attachment to secretor and nonsecretor epithelial cells of HB101 papIA2 and HB101 papAD110 were inhibited by globotetraosylceramide, while the Forssman glycolipid had no effect. The sheep erythrocyte reactivity and attachment to secretor epithelial cells of HB101 prsJ96 were inhibited by the Forssman glycolipid. These results permitted three conclusions. First, the expression of functionally active Gal alpha 1-4Gal beta-specific adhesins, as in HB101 papJ96, was not sufficient to make E. coli competent to attach to human uroepithelial cells. Attachment required P fimbriae of the papIA2 or papAD110 type. Second, the sheep erythrocyte reactivity of P-fimbriated strains could not be attributed solely to recognition of the Forssman glycolipid and may not be used to define the prsJ96-encoded phenotype. Third, the P-fimbrial adhesins which mediate secretor state-independent attachment to human uroepithelial cells recognized receptor epitopes provided by globotetraosylceramide.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1353483      PMCID: PMC257329          DOI: 10.1128/iai.60.8.3416-3422.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Electron microscopical observations on bacterial cytology; a study on flagellation.

Authors:  A L HOUWINK; W van ITERSON
Journal:  Biochim Biophys Acta       Date:  1950-03

2.  Globo-A--a new receptor specificity for attaching Escherichia coli.

Authors:  D Senior; N Baker; B Cedergren; P Falk; G Larson; R Lindstedt; C S Edén
Journal:  FEBS Lett       Date:  1988-09-12       Impact factor: 4.124

3.  Adhesion of Escherichia coli to human uroepithelial cells in vitro.

Authors:  C S Eden; B Eriksson; L A Hanson
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

4.  Globoside-specific adhesins of uropathogenic Escherichia coli are encoded by similar trans-complementable gene clusters.

Authors:  B Lund; F P Lindberg; M Båga; S Normark
Journal:  J Bacteriol       Date:  1985-06       Impact factor: 3.490

5.  Construction and expression of recombinant plasmids encoding type 1 or D-mannose-resistant pili from a urinary tract infection Escherichia coli isolate.

Authors:  R A Hull; R E Gill; P Hsu; B H Minshew; S Falkow
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

6.  Binding to galactose alpha 1----4galactose beta-containing receptors as potential diagnostic tool in urinary tract infection.

Authors:  S Enerbäck; A C Larsson; H Leffler; A Lundell; P de Man; B Nilsson; C Svanborg-Edén
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

Review 7.  P-fimbriae of pyelonephritogenic Escherichia coli: identification and chemical characterization of receptors.

Authors:  S B Svenson; H Hultberg; G Källenius; T K Korhonen; R Möllby; J Winberg
Journal:  Infection       Date:  1983 Jan-Feb       Impact factor: 3.553

8.  Selected ion monitoring of glycospingolipid mixtures. Identification of several blood group type glycolipids in the small intestine of an individual rabbit.

Authors:  M E Breimer; G C Hansson; K A Karlsson; H Leffler; W Pimlott; B E Samuelsson
Journal:  Biomed Mass Spectrom       Date:  1979-06

9.  Glucosamine-containing sphingoglycolipids from sheep erythrocytes.

Authors:  M Momoi; T Yamakawa
Journal:  J Biochem       Date:  1978-08       Impact factor: 3.387

10.  Glycolipid receptors for uropathogenic Escherichia coli on human erythrocytes and uroepithelial cells.

Authors:  H Leffler; C Svanborg-Edén
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

View more
  14 in total

1.  A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate.

Authors:  Thomas A Russo; Janet M Beanan; Ruth Olson; Stacy A Genagon; Ulrike MacDonald; John J Cope; Bruce A Davidson; Brian Johnston; James R Johnson
Journal:  Vaccine       Date:  2007-02-05       Impact factor: 3.641

2.  Characteristics and prevalence within serogroup O4 of a J96-like clonal group of uropathogenic Escherichia coli O4:H5 containing the class I and class III alleles of papG.

Authors:  J R Johnson; A E Stapleton; T A Russo; F Scheutz; J J Brown; J N Maslow
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

3.  Oral consumption of cranberry juice cocktail inhibits molecular-scale adhesion of clinical uropathogenic Escherichia coli.

Authors:  Yuanyuan Tao; Paola A Pinzón-Arango; Amy B Howell; Terri A Camesano
Journal:  J Med Food       Date:  2011-04-11       Impact factor: 2.786

4.  Novel molecular variants of allele I of the Escherichia coli P fimbrial adhesin gene papG.

Authors:  J R Johnson; A L Stell; N Kaster; C Fasching; T T O'Bryan
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

5.  Extraintestinal pathogenic Escherichia coli survives within neutrophils.

Authors:  Helen Nazareth; Stacy A Genagon; Thomas A Russo
Journal:  Infect Immun       Date:  2007-02-12       Impact factor: 3.441

6.  Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917.

Authors:  Lubomir Grozdanov; Carsten Raasch; Jürgen Schulze; Ulrich Sonnenborn; Gerhard Gottschalk; Jörg Hacker; Ulrich Dobrindt
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

7.  Structure and copy number analyses of pap-, sfa-, and afa-related gene clusters in F165-positive bovine and porcine Escherichia coli isolates.

Authors:  S N Maiti; J Harel; J M Fairbrother
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

8.  Epithelial glucosphingolipid expression as a determinant of bacterial adherence and cytokine production.

Authors:  M Svensson; R Lindstedt; N S Radin; C Svanborg
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

9.  Molecular cloning of Proteus mirabilis uroepithelial cell adherence (uca) genes.

Authors:  S W Cook; N Mody; J Valle; R Hull
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

10.  The multifunctional protein YdiV represses P fimbria-mediated adherence in uropathogenic Escherichia coli.

Authors:  Rachel R Spurbeck; Christopher J Alteri; Stephanie D Himpsl; Harry L T Mobley
Journal:  J Bacteriol       Date:  2013-05-10       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.